首页> Brachytherapy> Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone.

Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone.

导出原文传递

翻译打印收藏纠错

第一作者： Rossi PJ

作者： Rossi PJ ^[1] ; Urbanic J ; Clark PE ; McCullough DL ; Lee WR

作者单位： Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA. prosso@emory.edu ^[1]

关键词 Male population group Cancer of Prostate public service announcement month 复发

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Brachytherapy

2008年7卷4期

286-289页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Brachytherapy

2008年7卷4期

286-289页

检索历史清除

Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone.

Brachytherapy

相似文献

同项目论文

Brachytherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone.

Brachytherapy

相似文献

同项目论文

Brachytherapy

相关期刊

检索历史清除